Interleukin-2 maintains the survival of interleukin-17+ gamma/delta T cells in inflammation and autoimmune diseases
Authors:
- 1 September 2020
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 86, 106721
Abstract
No abstract availableKeywords
Funding Information
- Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park (Z181100001718040)
- National Natural Science Foundation of China (81703006)
This publication has 38 references indexed in Scilit:
- IL-17+ γδ T cells as kick-starters of inflammationNature Immunology, 2017
- Role of gamma-delta (γδ) T cells in autoimmunityJournal of Leukocyte Biology, 2014
- Early IL-17 Production by Intrahepatic T Cells Is Important for Adaptive Immune Responses in Viral HepatitisThe Journal of Immunology, 2013
- Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin InflammationImmunity, 2011
- Interleukin-17 Accelerates Allograft Rejection by Suppressing Regulatory T Cell ExpansionCirculation, 2011
- γδ T Cells Enhance Autoimmunity by Restraining Regulatory T Cell Responses via an Interleukin-23-Dependent MechanismImmunity, 2010
- Innate IL-17-producing cells: the sentinels of the immune systemNature Reviews Immunology, 2010
- The Contribution of γδ T Cells to the Pathogenesis of EAE and MSCurrent Molecular Medicine, 2009
- γδ T cells: an important source of IL-17Current Opinion in Immunology, 2008
- Gamma delta T-cell receptor repertoire in acute multiple sclerosis lesions.Proceedings of the National Academy of Sciences, 1992